Lv3
390 积分 2023-12-12 加入
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
5小时前
已完结
Viral hepatitis in children: what do we know in 2021?
5天前
已完结
Epidemiological Burden of Hepatitis Delta Virus in the United States
5天前
已关闭
Generative AI in Medicine — Evaluating Progress and Challenges
7天前
已完结
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis
24天前
已完结
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
1个月前
已完结
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)
1个月前
已完结
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
1个月前
已完结
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
1个月前
已完结
Long-term benefit of interferon α therapy of chronic hepatitis D: regression of advanced hepatic fibrosis
1个月前
已完结
皖公网安备34019202002308
